Study of Two Regimens of TicagrElor Compared to Clopidogrel in Patients Undergoing ELective Percutaneous Coronary Intervention
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 26 Dec 2017
At a glance
- Drugs Ticagrelor (Primary) ; Clopidogrel
- Indications Coronary artery disease
- Focus Pharmacodynamics
- Acronyms STEEL PCI
- 18 Dec 2017 Planned End Date changed from 1 Jul 2017 to 1 Jul 2018.
- 18 Dec 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Jul 2018.
- 10 Jun 2017 Biomarkers information updated